ASIAN BIOMEDICINE, cilt.4, sa.4, ss.627-630, 2010 (SCI-Expanded)
Background: Severe hyperlipidemia secondary to capecitabine, an oral fluoropyrimidine, is a very rare condition. There are no reported cases of hyperlipidemia associated with Uracil/tegafur (U FT).